Peter Blume-Jensen
2021
In 2021, Peter Blume-Jensen earned a total compensation of $756.8K as Chief Executive Officer, President and Director at Acrivon Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $215,000 |
|---|---|
| Option Awards | $111,771 |
| Salary | $430,000 |
| Total | $756,771 |
Blume-Jensen received $430K in salary, accounting for 57% of the total pay in 2021.
Blume-Jensen also received $215K in non-equity incentive plan and $111.8K in option awards.
Rankings
In 2021, Peter Blume-Jensen's compensation ranked 9,659th out of 12,415 executives tracked by ExecPay. In other words, Blume-Jensen earned more than 22.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,659 out of 12,415 | 22nd |
Division Manufacturing | 4,278 out of 5,508 | 22nd |
Major group Chemicals And Allied Products | 1,894 out of 2,378 | 20th |
Industry group Drugs | 1,680 out of 2,099 | 20th |
Industry Pharmaceutical Preparations | 1,250 out of 1,549 | 19th |
Source: SEC filing on May 1, 2023.
Blume-Jensen's colleagues
We found one more compensation record of an executive who worked with Peter Blume-Jensen at Acrivon Therapeutics in 2021.
2021
Eric Devroe
Acrivon Therapeutics